Molecule Structure

Scientific Name

Halothane

Description of the Drug

Halothane is a general inhalation anesthetic used for the induction and maintenance of general anesthesia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01159

Brand Name(s)

Fluothane, Halothane, Rhidialothan

Company Owner(s)

Bh Chemicals Inc, Wyeth Ayerst Laboratories, Hospira Inc, Halocarbon Laboratories Div Halocarbon Products Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Potassium channel subfamily K member 9 SINGLE PROTEIN OPENER CHEMBL2321614
Potassium channel subfamily K member 3 SINGLE PROTEIN OPENER CHEMBL2321613
Potassium channel subfamily K member 10 SINGLE PROTEIN OPENER CHEMBL2331041
Potassium channel subfamily K member 2 SINGLE PROTEIN OPENER CHEMBL2321615
Glycine receptor (alpha-1/beta) PROTEIN COMPLEX POSITIVE MODULATOR CHEMBL2363052
GABA-A receptor; anion channel PROTEIN COMPLEX GROUP POSITIVE ALLOSTERIC MODULATOR CHEMBL2093872
Potassium channel subfamily K member 18 SINGLE PROTEIN OPENER CHEMBL2331042

Unichem Links

Atlas halothane
SureChEMBL SCHEMBL25588
PharmGKB PA449845
Human Metabolome Database HMDB0015290
DrugBank DB01159
PubChem: Thomson Pharma 15067445
PubChem 3562
NMRShiftDB 20209476
Nikkaji J2.555K
BindingDB 50112212
EPA CompTox Dashboard DTXSID4025371
DrugCentral 1356
Brenda 15777
ChemicalBook CB8488628
Guide to Pharmacology 2401
rxnorm HALOTHANE
KEGG Ligand C07515
ChEBI 5615